Sherrington Robin has sold XENE and made no open-market buys since Jun 2021

Robin Sherrington is a Person and serves as Executive Vice President, Strategy & Innovation at Xenon Pharmaceuticals Inc., a role they have held since March 2019.( At Xenon, Dr. Sherrington has also held earlier leadership positions in business and corporate development after joining the company in March 2001.(

Before Xenon, Dr. Sherrington worked at Pfizer as a neuroscientist and previously served as Director of Neuroscience at Axys Pharmaceuticals and Sequana Therapeutics.( Their early career included scientific leadership in neuroscience genomics at Sequana, later work on genomics and disease-mechanism research at Axys, and responsibility at Pfizer for discovering and selecting novel psychotherapeutic targets.( Dr. Sherrington earned a Ph.D. in Human/Medical Genetics from University College London and a B.Sc. with honors in Microbiology, Biochemistry & Physiology from the University of Reading.(

Written by Perplexity from public sources.